Evaluation of the Therapeutic Effect and Local Tolerability of Elidel® Cream 1% (Pimecrolimus) in Chronic Discoid Lupus Erythematosus (dLE) or Subacute Cutaneous Lupus Erythematosus (scLE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00222183

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:53.371557+00:00

Published At

2018-06-28T00:00:00+00:00

Record Updated At

2018-06-28

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Lupus Erythematosus, Cutaneous", "Lupus Erythematosus, Discoid"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-06-28"

protocolSection.identificationModule.nctId

"NCT00222183"

protocolSection.identificationModule.officialTitle

"Evaluation of the Therapeutic Effect and Local Tolerability of Elidel\u00ae Cream 1% (Pimecrolimus) in Chronic Discoid Lupus Erythematosus (dLE) or Subacute Cutaneous Lupus Erythematosus (scLE)"

protocolSection.statusModule.overallStatus

"WITHDRAWN"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Lupus Erythematosus, Cutaneous (protocolSection.conditionsModule.conditions)
• Lupus Erythematosus, Discoid (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.